Based on our analysis of the Beat AML dataset, we observe a positive correlation between adverse overall survival and high FLI1 and ELF1 transcript levels in all non-acute promyelocytic leukemia patients, especially in CN-AML where MEIS1 levels are high. This evidence concerns the gene FLI1 and acute myeloid leukemia.